Newborn ICU admissions drop 50% in first full year of RSV maternal vaccine programme

• RSV maternal vaccination programme has achieved a 50% reduction in neonatal ICU admissions in its first full year of implementation, demonstrating significant clinical benefit.
• Despite 60% monthly vaccination uptake among pregnant women, UKHSA estimates thousands of babies remain unprotected, highlighting a substantial protection gap in the eligible population.
• Current vaccination coverage is insufficient to achieve maximum population-level protection, suggesting need for strategies to improve maternal uptake to protect more newborns from severe RSV disease.

While around 60% of women giving birth every month are vaccinated, UKHSA warns many thousands of babies still at risk.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.